3-Methoxycatechol (Standard)

[1]. Dias P, et al. 3-methoxycatechol causes vasodilation likely via K channels: ex vivo, in silico docking and in vivo study. Vascular pharmacology. 2024 Sep;156:107418.

[2]. Ma N, et al. NanoBiT screening identifies the azaoxafluorene VT11 as potent tau interaction inhibitor. Scientific reports. 2026 Aug 04;16(1):24013.

[3]. Salam R. Structure-Based Drug Discovery: Computational Insights into TGR5 Agonists and Substituted Catechol Vasodilators[J]. 2025.

[4]. Deng H, et al. The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists. Pharmaceuticals (Basel, Switzerland). 2013 Apr 08;6(4):500-9.

[5]. Bortolomeazzi R, et al. Comparative evaluation of the antioxidant capacity of smoke flavouring phenols by crocin bleaching inhibition, DPPH radical scavenging and oxidation potential[J]. Food chemistry, 2007, 100(4): 1481-1489.

[6]. Tao Y, et al. Altering toluene 4-monooxygenase by active-site engineering for the synthesis of 3-methoxycatechol, methoxyhydroquinone, and methylhydroquinone. Journal of bacteriology. 2004 Jul;186(14):4705-13. [Content Brief]

[7]. Hirose M, et al. Effects of sodium nitrite and catechol, 3-methoxycatechol, or butylated hydroxyanisole in combination in a rat multiorgan carcinogenesis model. Cancer research. 1993 Jan 01;53(1):32-7. [Content Brief]

[8]. Ito N, et al. Carcinogenicity and modification of carcinogenic response by plant phenols[J]. 1992.